SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-022813
Filing Date
2014-04-15
Accepted
2014-04-15 17:23:14
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v374697_10k.htm 10-K 771281
2 EXHIBIT 23.1 v374697_ex23-1.htm EX-23.1 2397
3 EXHIBIT 31.1 v374697_ex31-1.htm EX-31.1 9827
4 EXHIBIT 31.2 v374697_ex31-2.htm EX-31.2 9822
5 EXHIBIT 32.1 v374697_ex32-1.htm EX-32.1 5431
6 EXHIBIT 32.2 v374697_ex32-2.htm EX-32.2 5534
7 GRAPHIC tpg8.jpg GRAPHIC 89282
8 GRAPHIC tpg9.jpg GRAPHIC 133050
9 GRAPHIC tpg10a.jpg GRAPHIC 75721
10 GRAPHIC tpg10b.jpg GRAPHIC 43268
11 GRAPHIC tpg11.jpg GRAPHIC 53350
12 GRAPHIC tpg14.jpg GRAPHIC 31717
  Complete submission text file 0001144204-14-022813.txt   1393707
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23930 | Film No.: 14765854
SIC: 2836 Biological Products, (No Diagnostic Substances)